GMED GLOBUS MEDICAL INC
Price Chart
Executive Summary
The Federal Circuit reversed the PTAB's Final Written Decision, adopting Life Spine's broader construction of the claim term 'complementary with one another' to include mirrored angles. Under this construction, Globus conceded claims 10-14 of its '731 patent are obvious, rendering those claims unpatentable. This ruling removes a key patent from Globus's spinal implant portfolio, potentially exposing its expandable fusion devices to competition.
Court Ruling Details
Actionable Insight
The invalidation of claims 10-14 of the '731 patent removes a barrier to entry for competitors in the expandable spinal fusion device market. Monitor Globus's next earnings call for commentary on revenue impact and any plans to appeal or seek further patent protection. Competitors like Life Spine may now launch competing products, pressuring GMED's market share and pricing.
Key Facts
- Federal Circuit reversed PTAB's Final Written Decision in IPR2022-01434, adopting Life Spine's claim construction for 'complementary with one another' to include mirrored angles.
- Claims 10-14 of Globus's U.S. Patent No. 8,845,731 ('731 patent) held unpatentable as obvious under the new construction.
- The '731 patent covers expandable fusion devices used in spinal surgery, a core product area for Globus.
- Globus made no argument for nonobviousness under Life Spine's construction, leading to reversal.
- The ruling is nonprecedential but binding on the parties.
Financial Impact
Loss of patent protection for expandable fusion device claims, potentially impacting a significant portion of Globus's spinal implant revenue. No damages awarded.
Risk Factors
- Increased competition from Life Spine and other rivals in expandable spinal fusion devices.
- Potential revenue erosion if Globus's expandable fusion devices lose market share or face price pressure.
- Possible further IPR challenges to other Globus patents in the same family.
Market Snapshot
Documents Analyzed
This report is based on 1 court opinion from CourtListener.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-23o0yhd8-GMED |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 4, 2026
2d ago
|
8-K
| $80.05 awaiting T+1 | awaiting T+1 | — | $80.00 (−0.06%) |
|
Jun 4, 2026
2d ago
|
Court Ruling
| $80.00 $80.00 | · 0.00% | ▼ −2.60% | $80.00 (0.00%) |
|
Apr 24, 2026
6w ago
|
DEFA14A
| $93.70 $90.74 | ▼ −3.16% | ▼ −2.67% | $80.00 (−14.62%) |
|
Feb 24, 2026
14w ago
|
8-K
| $96.22 $96.71 | ▲ +0.51% | ▲ +1.05% | $80.00 (−16.86%) |
US Market Status
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access